A unique reason for coronary spasm causing temporary ST elevation myocardial infarction (inferior STEMI) - systemic inflammatory response syndrome after use of pembrolizumab
Status PubMed-not-MEDLINE Jazyk angličtina Země Polsko Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
29379889
PubMed Central
PMC5777475
DOI
10.5114/amsad.2017.72531
PII: 31415
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Department of Internal Medicine 1 Cardiology University Hospital Olomouc Czech Republic
Department of Pulmonary Diseases and Tuberculosis University Hospital Olomouc Czech Republic
Zobrazit více v PubMed
Collin M. Immune checkpoint inhibitors: the battle of giants. Pharm Pat Anal. 2017;6:135–7. PubMed
Läubli H, Balmelli C, Bossard M, Pfister O, Glatz K, Zippelius A. Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma. J Immunother Cancer. 2015;3:11. PubMed PMC
Heinzerling L, Ott PA, Hodi FS, et al. Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy. J Immunother Cancer. 2016;4:50. PubMed PMC
Zimmer L, Goldinger SM, Hofmann L, et al. Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy. Eur J Cancer. 2016;60:210–25. PubMed
